Skip to main content
Caplight Logo









Xias Bio

Xias Bio

Private
PaisleyHealthcare & Life Scienceshttps://xiasbio.com/

Last Round

Seed

Sep 4, 2024

Total Funding Raised

$5.1M

Company Overview

Xias Bio is a biotechnology company that develops sustainable, animal-free protein alternatives using its proprietary LiteProtein™ engineering platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, Sustainable Materials, Fashion & Beauty

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

recombinant proteinsanimal-free ingredientslab-grown proteinsbiofermentationprotein engineeringsynthetic biologycosmetic ingredientsbiotech manufacturingsustainable beautypeptide designin silico discoverycollagen alternativekeratin alternativeelastin alternativeB2B biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Xias Bio Comparables

Compare Xias Bio with similar companies based on industry and business-model similarity.

Xias Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cambrium
88%
Jellatech
85%
Geltor
84%

Xias Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 4, 2024

Key People

Founding team and executive leadership

Faadil Fawzy

Co-Founder & Chief Scientific Officer

Founding Team

Xias Bio Investors

Notable investors and investment history

Xias Bio investors
InvestorRounds
Good StartupSeed
Happiness CapitalSeed
CPT CapitalSeed
IndieBioAccelerator
BoxOne VenturesSeed
SOSVAccelerator, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 7, 2025

    Monthly visitors grew 2240% MoM, reaching 1.1K.

  • Dec 13, 2024

    Grew 50% QoQ, from 6 to 9 employees.

Xias Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Xias Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Xias Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersPaisley
Employee Range11
Year Founded2020
Last FundingSep 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?